HCMT
IART icon

Highland Capital Management (Tennessee)’s Integra LifeSciences IART Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14,071
Closed -$784K – 325
2019
Q1 		$784K Buy
+14,071
New +$717K 0.06% 247

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Highland Capital Management (Tennessee)'s IART Position: Q2 2019 in Review

Highland Capital Management (Tennessee) sold out of Integra LifeSciences (IART) in Q2 2019, closing a stake of 14,071 shares — an estimated $784K sold.

Highland Capital Management (Tennessee) first reported a position in IART in Q1 2019 and held it in 1 quarter. The position peaked at $784K in Q1 2019. 262 funds tracked by Wall St. Rank hold IART as of Q2 2019.

  • Highland Capital Management (Tennessee) reported no remaining Integra LifeSciences position as of Q2 2019 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 14,071 Integra LifeSciences shares in Q2 2019, an estimated $784K.
  • Highland Capital Management (Tennessee) first reported a position in Integra LifeSciences in Q1 2019 and held it in 1 quarter.
  • Highland Capital Management (Tennessee)'s Integra LifeSciences position peaked at $784K in Q1 2019.
  • 262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2019.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q2 2019, filed 29 Jul 2019.